Navigation Links
American Peptide Company Expands Their Large Scale cGMP Synthesis Capabilities
Date:8/26/2013

Sunnyvale, CA (PRWEB) August 26, 2013

American Peptide Company (APC) announces the expansion of their large scale cGMP peptide synthesis capabilities with the addition of a 300 Liter solid phase synthesis reactor and a 294 Liter tray lyophilizer.

American Peptide’s state of the art 35,000 square foot cGMP facility is located in Vista, California. The 300 Liter solid phase synthesis reactor is one of the largest in the U.S. peptide CMO industry. The 294 Liter tray lyophilizer has 15 square meters of shelf space and is the largest in the peptide CMO industry. Two additional 50 Liter tray lyophilizers have also been recently added to their cGMP facility.

The 294 Liter tray lyophilizer is equipped with a Clean In Place (CIP) skid to eliminate cross contamination between batches. The temperature of each step is controlled, and the conductivity of the water is monitored. The control system includes full PLC automation with 21 CFR parts 210, 211 compliant operation and a well-documented SOP.

These new pieces of equipment are complimented by an existing array of synthesis reactors, lyophilizers and large scale purification columns.

With the expansion of their large scale cGMP synthesis capacity, American Peptide Company can produce multi-kilograms of active pharmaceutical ingredients in individual batches. Large scale peptide synthesis helps make the process more economical and shortens delivery times.

###

About American Peptide Company, Inc.
American Peptide Company (APC) is a leading manufacturer of peptides and peptide conjugates. The company offers comprehensive selections of pre-manufactured catalog peptides, custom synthesis, and GMP peptide active pharmaceutical ingredients (APIs). Our California based manufacturing facilities offer synthesis services under Non GMP (Sunnyvale, California) and cGMP (Vista, California) conditions. Our cGMP manufacturing is performed under strict adherence to FDA Regulations 21 CFR parts 210, 211 and ICH Guidance Q7A. Our Total Peptide Management services support clients in the drug development process from pre-clinical thru commercial stage. Our value added services include process development, scale up production, analytical/process validation, stability studies, CMC, DMF, and regulatory support.

For more information, please visit http://www.americanpeptide.com.

Read the full story at http://www.prweb.com/releases/peptide/synthesis/prweb11055041.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Zane Benefits Publishes New Information on How Many Americans will Qualify for Premium Tax Credits
2. Inc. Magazine Names AvePoint to the Inc. 500
3. 5000 List of Fastest Growing American Companies for the Fourth Consecutive Year
4. Kenneth Bernstein, M.D., receives Distinguished Scientist designation from American Heart Association
5. American Farmer Announces Upcoming Episode on Maple Syrup Production to Air on RFD-TV
6. American Society for Aesthetic Plastic Surgery Advises Consumers to Avoid Unqualified Personnel Performing Cosmetic Procedures
7. American Scientists Attempt to Sequence John Lennon's Genetic Code from the Beatle's Tooth
8. Journal of the American College of Cardiology Taps Next Editor-in-Chief
9. Experiences of racism linked to adult-onset asthma in African-American women
10. Stroke declines dramatically, still higher in Mexican Americans
11. Vaginal Mesh Lawsuit News: Bernstein Liebhard LLP Notes New Order in Federal Litigation for American Medical Systems Mesh Lawsuits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... ... temporary closing of Bruton Memorial Library on June 21 due to a possible lice infestation, ... aspect of head lice: the parasite’s ability to live away from a human host, and ... necessary one in the event that lice have simply gotten out of control. , As ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... To deal with these feelings, many turn to unhealthy avenues, such as drug or ... Center of Marne, Michigan, has released tools for healthy coping following a traumatic event. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. ... The attorneys chosen by their peers for this recognition are considered among the top ... Shareholders received special honors as members of this year’s Legal Elite Hall of Fame: ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their pencils ... an essay contest in which patients and their families pay tribute to a genetic ... 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the addition of ... report to their offering. ... kidney failure, it replaces the function of kidneys by removing ... thus the treatment helps to keep the patient body,s electrolytes ... Increasing number of ESRD patients & substantial healthcare expenditure ...
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
Breaking Medicine Technology: